Article

Bausch & Lomb names chief medical officer

Bausch & Lomb named Brian Levy, MD, its corporate vice president and chief medical officer, placing him responsible for pre-clinical, clinical, and medical affairs for all of the company's businesses worldwide.

Related Videos
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
1 expert is featured in this series.
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Related Content
Cost-effectiveness of AI pediatric eye screening
January 17th 2025

Cost-effectiveness of AI pediatric eye screening

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

City Therapeutics and Bausch + Lomb partner on geographic atrophy treatment candidate
January 16th 2025

City Therapeutics and Bausch + Lomb partner on geographic atrophy treatment candidate

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

4DMT releases positive topline interim data from Part 1 of the SPECTRA clinical trial
January 15th 2025

4DMT releases positive topline interim data from Part 1 of the SPECTRA clinical trial

RhyGaze secures Series A financing of $86 million to further novel gene therapy
January 15th 2025

RhyGaze secures Series A financing of $86 million to further novel gene therapy

© 2025 MJH Life Sciences

All rights reserved.